De Faire Medical UK Ltd 14236246 false 2022-07-15 2023-07-31 2023-07-31 The principal activity of the company is Manufacture of other food products not elsewhere classified Digita Accounts Production Advanced 6.30.9574.0 true true 14236246 2022-07-15 2023-07-31 14236246 2023-07-31 14236246 bus:SmallEntities 2022-07-15 2023-07-31 14236246 bus:AuditExemptWithAccountantsReport 2022-07-15 2023-07-31 14236246 bus:FilletedAccounts 2022-07-15 2023-07-31 14236246 bus:SmallCompaniesRegimeForAccounts 2022-07-15 2023-07-31 14236246 bus:RegisteredOffice 2022-07-15 2023-07-31 14236246 bus:Director1 2022-07-15 2023-07-31 14236246 bus:Director2 2022-07-15 2023-07-31 14236246 bus:Director3 2022-07-15 2023-07-31 14236246 bus:PrivateLimitedCompanyLtd 2022-07-15 2023-07-31 14236246 countries:England 2022-07-15 2023-07-31 iso4217:GBP xbrli:pure

Registration number: 14236246

De Faire Medical UK Ltd

Unaudited Filleted Abridged Financial Statements

for the Period from 15 July 2022 to 31 July 2023

 

De Faire Medical UK Ltd

Contents

Company Information

1

Abridged Balance Sheet

2

Notes to the Unaudited Abridged Financial Statements

3

 

De Faire Medical UK Ltd

Company Information

Directors

Mr Johan De Faire

Mr Hakan Magnusson

Registered office

Carpenter Court 1 Maple Road
Bramhall
Stockport
Cheshire
SK7 2DH

Accountants

Onyx Accountants Limited
Chartered Management Accountants
Onyx House
12 Phoenix Business Park
Avenue Close
Birmingham
West Midlands
B7 4NU

 

De Faire Medical UK Ltd

(Registration number: 14236246)
Abridged Balance Sheet as at 31 July 2023

Note

2023
£

Current assets

 

Cash at bank and in hand

 

1,000

Capital and reserves

 

Called up share capital

1,000

Shareholders' funds

 

1,000

For the financial period ending 31 July 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 8 April 2024 and signed on its behalf by:
 

.........................................
Mr Johan De Faire
Director

 

De Faire Medical UK Ltd

Notes to the Unaudited Abridged Financial Statements for the Period from 15 July 2022 to 31 July 2023

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Carpenter Court 1 Maple Road
Bramhall
Stockport
Cheshire
SK7 2DH
United Kingdom

These financial statements were authorised for issue by the Board on 8 April 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Staff numbers

The average number of persons employed by the company (including directors) during the period, was 1.